The identification and selection of suitable biomarkers is critical to the successful translation of laboratory research into effective clinical trial outcomes. Biomarkers can include molecules such as cells, proteins, protein modifications, nucleic acids, metabolites, and other substances that can be detected in blood, urine, tissues, or other bodily fluids. Biomarkers are essential in drug development to assess the efficacy and safety of new drugs. Using our custom biomarker services, we can help you determine the optimal method for detecting and measuring biological responses to an intervention or within a disease setting, at any stage of the drug development pipeline. We utilise advanced technologies to assist with biomarker discovery, assay development and validation as well as clinical trial sample analysis. Our tailored solutions and bespoke method optimisation ensures the most reliable and efficient approach is utilised in your scientific program.
Connected servicesMore informationSpeak to an expertThe identification and selection of suitable biomarkers is critical to the successful translation of laboratory research into effective clinical trial outcomes. Biomarkers can include molecules such as cells, proteins, protein modifications, nucleic acids, metabolites, and other substances that can be detected in blood, urine, tissues, or other bodily fluids. Biomarkers are essential in drug development to assess the efficacy and safety of new drugs.
Using our custom biomarker services, we can help you determine the optimal method for detecting and measuring biological responses to an intervention or within a disease setting, at any stage of the drug development pipeline. We utilise advanced technologies to assist with biomarker discovery, assay development and validation as well as clinical trial sample analysis. Our tailored solutions and bespoke method optimisation ensures the most reliable and efficient approach is utilised in your scientific program.